February, 2016 -A consortium led by VCN Biosciencesreceives funding for Cure4RBproject (RTC-2015-4319-1)by Ministerio de Economía y Competitividad (MINECO)from Spanish Government, programRETOS DE COLABORACIÓN -2015.
This projectaims todevelopVCN-01 as a new clinical treatment for paediatric patients suffering from retinoblastoma, the most common ocular malignancy during childhood.The consortium also involves research groups from Fundació Sant Joan de Deu (Barcelona), ICO(Institut Català d’Oncologia)and Laboratorios Reig Jofre SA that will work together to initiate clinical trials with VCN-01 in this indication during 2016.